Visiting Professors

HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies

Feb. 14, 2025

02:02:17

Hepatocellular Carcinoma — Proceedings From a Session Held in Conjunction with the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI)

Feb. 12, 2025

01:58:47

5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Feb. 7, 2025

10:06

EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Feb. 5, 2025

01:00:02

Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani

Feb. 3, 2025

46:45

5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Jan. 31, 2025

11:58

Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series

Jan. 29, 2025

59:28

Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients

Jan. 24, 2025

01:00:17

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Jan. 22, 2025

59:32

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

Jan. 17, 2025

01:00:59

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Jan. 15, 2025

02:00:29

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Jan. 13, 2025

01:59:15

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

Jan. 10, 2025

02:01:00

Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Jan. 8, 2025

01:27:00

Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Jan. 6, 2025

01:58:51

The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2

Jan. 3, 2025

02:00:37

HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1

Dec. 23, 2024

01:31:29

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Dec. 20, 2024

01:57:11

Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Dec. 18, 2024

01:57:07

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

Dec. 18, 2024

49:11

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

Dec. 18, 2024

55:50

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

Dec. 17, 2024

46:41

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

Dec. 17, 2024

51:43

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

Dec. 13, 2024

51:45

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

Dec. 13, 2024

48:03

5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Dec. 13, 2024

11:59

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Dec. 10, 2024

58:47

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

Dec. 4, 2024

59:42

Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria

Dec. 3, 2024

01:46:37

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma

Nov. 26, 2024

52:45

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Nov. 25, 2024

10:56

The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences

Nov. 22, 2024

01:00:12

Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series

Nov. 22, 2024

58:36

Optimizing the Management of Tenosynovial Giant Cell Tumor

Nov. 20, 2024

01:03:55

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer

Nov. 20, 2024

57:10

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Nov. 20, 2024

56:11

Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Nov. 18, 2024

56:49

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer

Nov. 15, 2024

01:05:42

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer

Nov. 15, 2024

01:03:53

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Nov. 8, 2024

56:15